ArticleEJNMMI research2018

Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.

Yvonne W S Jauw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.